As most HCC recurrences occurred within 1 year after liver resection, we next analyzed whether URI and SCD1 expression is associated with 1-year recurrence free survival rate (RFS) of patients received adjuvant sorafenib treatment (Supplementary Fig. 11c, d). The gene discussed is SCD; the disease is hepatocellular carcinoma.